Search research articles
Contact Us
Filters
Showing results (131-140 of 223) with videos related to
Page
of 23
Sort By:
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
KBTBD4 Cancer Hotspot Mutations Drive Neomorphic Degradation of HDAC1/2 Corepressor Complexes
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
The American Journal of Pathology
|
September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Dat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Acta Neuropathologica
|
October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
Christian Koelsche, Felix Sahm, David Capper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Marc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Cancer Cell
|
February 21, 2012
An animal model of MYC-driven medulloblastoma
Yanxin Pei, Colin E Moore, Jun Wang, et al.
Acta Neuropathologica
|
December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials
Anthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Nature
|
February 12, 2025
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Nature Communications
|
May 26, 2022
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
Jennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Nature Communications
|
December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
Jennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 223) with videos related to
Sort By:
Page
of 23
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
KBTBD4 Cancer Hotspot Mutations Drive Neomorphic Degradation of HDAC1/2 Corepressor Complexes
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
The American Journal of Pathology
|
September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Dat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Acta Neuropathologica
|
October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
Christian Koelsche, Felix Sahm, David Capper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Marc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Cancer Cell
|
February 21, 2012
An animal model of MYC-driven medulloblastoma
Yanxin Pei, Colin E Moore, Jun Wang, et al.
Acta Neuropathologica
|
December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials
Anthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Nature
|
February 12, 2025
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Nature Communications
|
May 26, 2022
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
Jennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Nature Communications
|
December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
Jennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Page
of 23